Launch Offer Ends ..
- 00Days
- 00Hrs
- 00Mins
- 00Secs
Day One - Pre-Day - Western European Summer Time (WEST)
Join an exclusive gathering of CEOs, founders, and C-suite from growth-stage biotech companies for a candid, closed-door discussion addressing the most pressing challenges facing biotech companies in growth today. Away from the spotlight of public forums, participants can speak openly in a facilitated discussion about the real challenges they face and leave with actionable insights, expanded networks, and practical strategies to accelerate your biotech venture's growth while avoiding common pitfalls.
This closed-door forum operates under Chatham House rules, ensuring participants can share candidly without attribution. The discussion-based format encourages active participation for deeper exploration of specific challenges relevant to your business stage and therapeutic focus.
Join an exclusive gathering of CEOs, founders, and C-suite from early-stage medtech companies (pre-revenue through early commercialization) for a candid, closed-door discussion addressing the most pressing challenges facing early-stage medical technology companies today. Away from the spotlight of public forums, participants can speak openly in a facilitated discussion about the real challenges they face and leave with actionable insights, expanded networks, and practical strategies to accelerate your medtech venture's growth while avoiding common pitfalls.
This closed-door forum operates under Chatham House rules, ensuring participants can share candidly without attribution. The discussion-based format encourages active participation for deeper exploration of specific challenges relevant to your business stage and therapeutic focus.
Join an exclusive gathering of CEOs, founders, and C-suite from early-stage biotech companies for a candid, closed-door discussion addressing the most pressing challenges facing early-stage biotech companies today. Away from the spotlight of public forums, participants can speak openly in a facilitated discussion about the real challenges they face and leave with actionable insights, expanded networks, and practical strategies to accelerate your biotech venture's growth while avoiding common pitfalls.
This closed-door forum operates under Chatham House rules, ensuring participants can share candidly without attribution. The discussion-based format encourages active participation for deeper exploration of specific challenges relevant to your business stage and therapeutic focus.
Navigate the complex landscape of pharmaceutical partnerships, licensing agreements, and strategic transactions in this comprehensive forum. This strategic partnering forum brings together early-stage biotech executives to explore pathways for successful partnerships, licensing deals, and acquisition opportunities. Participants will gain practical insights into deal structures, valuation methodologies, milestone frameworks, due diligence preparation, and regulatory considerations that impact partnership agreements.
This 90-minute session combines expert insights with interactive Q&A and open discussion, featuring real-world examples and practical frameworks and insights. Designed for CEOs, and decision makers from early-stage biotech companies with assets suitable for pharmaceutical partnerships or acquisition, attendees will develop actionable partnership strategies, understand market dynamics, and engage in candid discussions about the challenges and opportunities in today's pharma partnering landscape.